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Microarray Data from a 
Statistician’s Point of View
microarray analysis. So my goal is to give an overview 
of the analysis process and the related statistical issues.
Why Microarrays?
Information (that can be obtained from microarrays) 
about genes helps us answer a myriad of biological 
questions:
• What genetic differences are there between 
healthy people and people with a particular disease?
• Are there genetic subgroups of people with a 
particular disease who respond positively to a given 
treatment?
• What kinds of genetic changes happen across 
time or after frequent doses of a treatment?
• Which genes are co-regulated—have expression 
levels that increase or decrease concurrently—in a 
particular biological system?
• What is the likelihood of acquiring a particular 
disease, given a person’s genetic make-up?
What is a Microarray?
DNA microarrays, first introduced commercially in 
1996, come in a variety of forms, but they all contain 
the same basic design. Each microarray consists of 
thousands of single strands of genetic material tethered 
to a “chip” the size of a thumbprint. The chips (which 
are not reusable and should not be confused with 
computer chips that can store and restore information) 
are produced at numerous academic and research 
laboratories, and they are also produced commercially. 
Microarray technology uses a fundamental property 
of DNA called “complementary base pairing.” Our DNA 
gives the blueprint for the functioning of the cell written 
in sequences of chemical bases: adenine (A), cytosine 
(C), guanine (G), and thymine (T). These bases bind 
in a double helix structure to create the DNA molecule 
(See Figure 1). At each rung along the DNA ladder, A 
always binds with T, and C always binds with G. Thus 
A is complementary to T, and C is complementary to 
G. Each spiral strand is connected to a complementary 
Reports in the news often tell about how genes determine the chances of getting a particular disease or how a genetic mutation can increase susceptibility 
to certain environmental changes. For example, Familial 
Adenomatous Polyposis (FAP) is a type of colon cancer 
that affects one in 8,000 people in the United States. 
FAP is caused by a mutation in the adenomatous polyposis 
coli (APC) gene. It has been estimated that a person with 
FAP has over three times the relative risk of dying than a 
person without FAP (Nugent et al. 1993).
It is well known that the DNA in a cell’s nucleus 
contains the instructions for building proteins. A gene 
is a segment of DNA that contains the instructions for 
building a specific protein. If different genes are active, 
then different proteins will be produced in a cell. Skin 
cells are different from muscle cells, for example, 
because different proteins are present in the two 
different types of cells. When a gene is active in a cell, 
we say that the gene is “expressed.” Information about 
genetic activity can give insight into biologic processes 
and cell behavior—both normal and cancerous.  
Measuring genetic activity is the role of molecular 
biologists. Until recently, scientists analyzed gene activ-
ity one gene at a time. Now activity can be measured 
on tens of thousands of genes simultaneously using 
a new tool known as a DNA microarray (Eisen and 
Brown, 1999). Interpreting the gene expression data is 
the role of statisticians. The huge volume of data from 
microarray analyses brings new statistical challenges 
and the need for new analytical techniques. 
As statisticians, our role in many scientific fields, 
particularly in the field of molecular biology, is vital and 
fascinating. Because microarray data analysis is a new 
and expanding research area, I cannot hope to cover 
in this article all of the current research associated with 
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strand by the paired bases. A subsequence of the gene 
characterized by TGAAACT on one strand would have 
ACTTTGA on the complementary strand of the DNA 
molecule.
The DNA code is identical in each cell nucleus 
through the entire body. However, in order for cells 
to function appropriately, each different cell type 
receives a different message from the DNA. A segment 
of DNA is converted into an intermediary form known 
as messenger RNA (mRNA) that exits the nucleus and 
serves as a template for building proteins.
Consequently, we could determine which genes 
are expressed in a cell by measuring the quantity of 
mRNA there is in the cell corresponding to that gene. 
However, free mRNA in a cell is very unstable, so it is 
treated with an enzyme to convert the mRNA back into 
DNA. This form of DNA is known as complementary 
DNA (cDNA).
Through a denaturing process the double-stranded 
DNA molecules in the sample are unzipped down 
the middle into two single-stranded molecules. The 
microarray chip itself also contains single strands of 
genes that will attract the single gene strands from the 
sample. The single strands from the sample will bind 
with the single strands on the microarray chip to reform 
the DNA double helix.
In a microarray experiment, the test sample is 
labeled with a dye and a reference sample is labeled 
with a dye of a different color. The reference sample 
serves as a control to which the gene expression in the 
test sample is compared. For instance, if we wanted 
to determine which genes are expressed in a tumor 
sample, we could use a tissue sample from a healthy 
individual as the reference sample. We would then 
compare the expression level of each gene in the tumor 
sample to the expression level of each gene in the 
reference sample. Suppose the tumor sample had been 
labeled with a red dye and the reference sample had 
been labeled with a green dye. Then a red spot on the 
microarray would indicate that the gene corresponding 
to that spot is expressed at a higher level in the tumor 
sample than in the reference sample. Similarly, a green 
spot would indicate that the gene is expressed at a 
lower level in the tumor sample.
There are several techniques for constructing DNA 
microarrays (Schena et al. 1995; Velculescu et al. 1995; 
Lockhart et al. 1996). Though there are slight differences 
in the microarray technologies, one basic outline of the 
microarray procedure can be summarized as follows:
   1. Label the sample with a fluorescent dye.
   2. Isolate the cDNA from the cells of interest, e.g.,  
      tumor cells, plasma cells, etc.
   3. Denature the sample so that the cDNA are in  
      single strands instead of the double helix form.
   4. Place the sample onto the microarray chip and   
      allow the double helix structure to restore itself.
   5. Wash the remaining sample off the chip so only  
      the parts of the sample that have bound to the  
      chip remain.
   6. Scan the microarray chip with a laser to quantify  
      the fluorescence of each individual gene. The  
      more of the sample that is stuck to the chip, the  
      higher the fluorescence.
A. Malcolm Campbell at Davidson College has put 
together an animation of the microarray process which 
can be seen at website: www.bio.davidson.edu/courses/
genomics/cgip/chip/html.
In general, the amount of activity of a gene is 
represented by the number of replicates of that gene in 
a particular sample of cells. A high fluorescence level 
indicates that multiple copies of a gene have bound to 
the chip and that the gene has high activity in the cell. 
Similarly, a low fluorescence level indicates low activity 
of the gene in the cell. By quantifying the fluorescence, 
the gene activity can be compared across different 
samples, e.g., a group of healthy samples compared to 
a group of tumor samples.
A sample scan of part of a chip is shown in Figure 2 
(see page 6). The image shown in the figure is only part 
of the chip. Each spot represents a gene and there are 
thousands of genes on a chip. A red spot indicates that 
sample 1 (the “red” sample) has high genetic activity 
for that gene. A green spot indicates that sample 2 
(the “green” sample) has high genetic activity for that 
gene. The yellow spots indicate the genes where the 
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Figure 1. Illustration of the DNA double helix molecule showing the 
complementary base pairing on the rungs of the DNA ladder.
ASA6 STATS 42       WINTER 2005n
two samples have similar activity, and the black spots 
indicate where there is no activity. 
An example of some microarray data is given in 
Table 1. The data came from an experiment on aging 
yeast in Laura Hoopes’ lab at Pomona College. The test 
sample (treatment) contains older yeast cells, while the 
reference sample (control) contains younger yeast cells. 
The test sample was dyed red and the reference sample 
was dyed green. The table only shows the expression 
level of ten genes as an illustration. In an actual analysis 
there would be data for many more genes. 
From the numerical values we can identify the genes 
that are highly expressed overall in the experiment and 
the genes that are just barely expressed. Note genes 
RPS11b and YBR124W, for example.
Additionally, by taking the ratio of intensities we 
can identify the genes that are most highly expressed 
in the treatment sample relative to the control sample 
and vice versa. Taking the logarithm of the ratio helps 
to further distinguish the genes with the highest and 
lowest relative expression levels. Note genes HSP26 and 
YRO2, for example.   
What is the Statistician’s Role?
Although it is preferable for the statistician to have 
a hand in the experimental design, the statistician often 
comes into a microarray analysis project once the data 
have been collected. The statistician’s job is to use the 
numerical fluorescence levels to make claims about the 
populations of interest. Of course, the methodology will 
depend on the question at hand. The computations can 
be broken down into two main parts: data cleaning and 
data analysis.
Though the microarray construction seems 
straightforward in theory, in reality there are numerous 
sources of variation. For example:
    • Spots that are not systematically placed on the chip,
    • Samples that smear outside of the measurement 
surface,
    • Dyes that fluoresce at different levels (green is 
“stronger” than red), or
    • Arrays with a variable amount of dye.
To address these problems, the data cleaning 
step involves image processing, normalization, and 
standardization. Current research on all three cleaning 
steps is active and growing. In this article I focus on 
data analysis instead of data cleaning, assuming the data 
are already “clean.” Many software programs designed for 
microarray analysis give options for cleaning the data.
Figure 2. Part of a microarray chip. Each spot represents one 
gene and the color represents the activity level of the gene in the 
test sample.
Table 1. Sample microarray data from an experiment on aging 
yeast cells. Red intensity refers to the test sample and green 
intensity refers to the reference sample. The ratio of intensities tells 
us the multiplicative change and the log base-2 ratio gives the 
difference of the data after a log transformation. Data courtesy of 
Laura Hoopes of Pomona College. 
Gene
  YBR124W
  YBR100W
  MRS5
  ECM33
  YBR075W
  HSP26
  VAP1
  YRO2
  YBR051W
  RPS11B
Red
Intensity
        92
       103
       369
      3423
       196
       805
       158
       118
       125
      3855
Green
Intensity
        78
        77
       357
      2663
       133
       175
       175
       373
       135
      3739
Ration of
Intensities
      1.179
      1.338
      1.008
      1.285
      1.474
      4.600
      0.903
      0.316
      0.926
      1.031
Log 2 of
Ratio
      0.238
      0.420
      0.012
      0.362
      0.559
      2.202
     -0.147
     -1.660
     -0.111
      0.044
Figure 3. Plot from the SAM analysis for the MM versus MGUS 
comparison. Each dot represents a particular gene. The x-
coordinate is the observed value of the test statistic and the 
y-coordinate is the expected value of the test statistics under 
hundreds of permutations. The dotted boundary is the cutoff for 
significance given a specified false discovery rate.
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those genes that are significant using both types of 
comparisons. 
Other methods have been developed to compare 
two groups in the context of microarray data. Some 
researchers have used a modification of the t-test 
(Golub et al. 1999). Researchers at Stanford University 
have developed a software package (SAM—Significant 
Analysis of Microarrays) to conduct a permutations 
test to establish cutoffs for the pairwise comparisons 
(Tusher et al. 2001; Tibshirani et al. 2002).
The SAM technique applied to the MM versus 
MGUS data identified 229 genes as showing significant 
activity. The false discovery rate (FDR) was only about 
three genes based on hundreds of random permutations 
of the gene values. Figure 3 (see page 6) shows an 
output plot from the SAM analysis.
For comparison, Table 2 presents the results of the 
t-test, the Wilcoxon test, and the SAM method.
Comparing Multiple Groups
Since the data actually contain three groups (MM, 
MGUS, and healthy groups), we could use analysis of 
variance (ANOVA) to find genes that have an average 
expression level that is different in at least one group. 
Just as we used a nonparametric version of the t-test 
(Wilcoxon rank sum test) in the two-group comparison, 
we could also use a nonparametric version of ANOVA 
(Kruskal-Wallis test) to analyze non-normal data from 
more than two groups. Each of these tests produces 
a p-value for the difference across the groups for 
every single gene. Significant differences can then be 
identified based on the magnitude of each p-value.    
Classification
Sometimes the research question has to do with 
predicting class membership in a set of data for which 
the classes are already known, that is, classifying a new 
sample into a known class. In this situation, we could 
use past data to set up a logistic regression model that 
can classify a future sample data point. One way to 
test the accuracy of the model is to classify a subset of 
points with known class membership that was not used 
in building the model. These independent data values 
will give unbiased information about the accuracy of 
What is an Example of Microarray 
Analysis?
To illustrate some of the typical statistical techniques 
applied to microarray data, let’s examine a real data 
set from a particular type of commercial chip— 
Affymetrix (version 5). The samples were taken from 
three populations: a group with multiple myeloma (a 
blood cancer abbreviated MM), a group with signs of 
developing MM (abbreviated MGUS for “monoclonal 
gammopothy of undetermined significance”), and a 
healthy group.
In this situation, plasma cells from each of the test 
subjects were isolated and placed on a microarray chip 
since multiple myeloma is characterized by plasma 
cells replicating out of control, which in turn causes 
organ damage. The Affymetrix chip measures 12,625 
genes simultaneously. There were 218 MM samples, 
21 MGUS samples, and 45 healthy samples. The data 
were collected at the Donna D. and Donald M. Lambert 
Laboratory of Myeloma Genetics, University of Arkansas 
for Medical Sciences by John Shaughnessy, Jr., and his 
colleagues (Zhan et al. 2002).
What Statistical Techniques Can We Use?
The tools from basic statistics can be used to address 
many microarray research questions; however, each 
research hypothesis requires a different statistical tool.
Comparing Two Groups
Probably the most common research question 
associated with microarray data is the two group 
comparison: What differences in genetic activity are there 
between one group of samples and another group of 
samples? Usually the first group of samples comes from 
people with a particular disease and the second group 
comes from healthy people. We’d like to know what type 
of genetic activity differentiates the two groups.
For example, we might be interested in comparing 
the MM group with the MGUS group. The t-test from 
basic statistics can be used to test whether the means of 
the two populations are the same. By applying the t-test 
separately to each of the 12,625 genes on the chip, we 
can tell which genes have an average gene expression 
that is different between the two groups. In the multiple 
myeloma example the t-test found 422 gene comparisons 
with p-values less than 0.001. Such a p-value indicates 
that the probability is less than one in a thousand that 
the difference occurred simply by chance.
When the t-test is not appropriate (when the data 
are not normally distributed, for example), we could 
use the Wilcoxon rank sum method to test whether 
the median expression levels are the same in the 
two populations. In the multiple myeloma example 
the Wilcoxon rank sum test found 341 gene comparisons 
with p-values less than 0.001. In comparing the MGUS 
and MM samples, the intersection of the genes 
with p-values less than 0.001 for both the t-test and 
the Wilcoxon rank sum test was a set of 269 genes. 
One analysis approach is to investigate further only 
Comparison
 
MM versus 
MGUS
t-Test
422
Wilcoxon Rank 
Sum Test
341
SAM
(FDR=3/229)
229
By Chance
12.63
Number of Significant Genes
(p < 0.001)
Table 2. The number of genes judged by each method to have a 
statistically significant expression level in comparing the MM and 
MGUS groups. Note that with α = .001 there could have been 
12.63 genes identified as significant simply by chance even if 
there was no effect due to the disease.
the classification procedure. When applied to an entire 
dataset, this procedure is called cross validation. The 
algorithm for the cross validation procedure is:
   1. Partition the data into k groups of the same size.
   2. Remove the first group from the data and build   
      the model on the remaining k-1 groups.
   3. Test the removed group of data using the above  
      model and record the  predicted class  
      membership.
   4. Repeat steps 2 and 3 for each of the k groups.
   5. Compile the false positive and the false negative  
      rates as a measure of model accuracy.
Using logistic regression with expression level as 
the explanatory variable and the disease groups (MM 
vs. healthy, MM vs. MGUS, healthy vs. MGUS) as the 
response variable, we can create models that predict the 
classification of future observations into dichotomous 
categories such as sick or healthy. The accuracy of 
these three separate models was evaluated using cross 
validation. The results are displayed in Table 3. 
It is apparent from the results that logistic regression 
using gene expression values can be used to discriminate 
between the healthy group and the malignant groups, 
but it is not useful for discriminating between the 
two malignant groups (MM and MGUS). This lack of 
discrimination is seen in the comparison of MM versus 
MGUS where most of the MGUS samples (62%) were 
incorrectly predicted to be from MM patients.
This and other discrimination methods for microarray 
analyses have been compared using cross validation 
prediction error rates (Hardin et al. 2004).
Clustering
Clustering is a process by which data can be 
grouped without any preconceived knowledge of the 
groupings or even of the number of groups. While 
classification models are referred to as “supervised 
learning,” clustering is sometimes referred to as 
“unsupervised learning.” As with most techniques, 
there are different clustering algorithms, yet many use 
some type of metric to establish a distance between 
two samples or two groups of samples. The concept in 
clustering is that the closer two items are to each other, 
the more likely they are related and should therefore be 
grouped together.
Clustering techniques provide a visual representation 
of patterns in the data. Groupings or clusters can 
illustrate relationships that may or may not be known 
by the researcher. For example, a particular clustering 
result may demonstrate what gene expressions are 
useful for characterizing genes with known functions. 
Or, a clustering result may lead to the discovery of 
groups of genes that have similar expression patterns. 
Clustering can also be performed on samples instead of 
genes. When we cluster samples, we look for similar 
genetic patterns in groups of individuals.
In hierarchical clustering, the first step is to link 
the two closest samples. Subsequently, that pair is 
compared to the remaining samples and either another 
two samples are linked or the first pair (cluster) is linked 
to a third sample based on which of these choices 
represents a shorter distance. This process continues 
until every sample in the data set is linked to another.
Figure 4 (see page 10) shows the sequential linkages 
of a sample of patients in our Multiple Mylenoma 
example. Each vertical line represents one sample. The 
samples from healthy people are labeled “X” and the 
samples from the MGUS patients are labeled “MGUS.” 
The MM samples are not labeled.
We can see that the MM samples tend to cluster 
together to the left and the healthy samples tend 
to cluster to the right, while the MGUS samples are 
dispersed throughout. This could indicate that maybe 
some of the MGUS samples will develop into MM while 
others of them will remain benign.
To illustrate the clustering process, figure 5 (see page 
10) is a magnification of the grouping of predominantly 
healthy patients on the right side of figure 4. For merges 
of a pair of samples, the value on the y-axis represents 
the Euclidean distance between the two samples. 
Where two clusters are merged, the value on the y-axis 
represents the average of the distances between each of 
the samples in one cluster and each of the samples in 
the other cluster. Notice that merges shown at the lower 
portion of the graph are samples that are the closest to 
each other (most similar), while merges shown at the 
upper portion of the graph are samples that are the 
farthest apart (least similar). 
Figures 6 (see page 11) shows clusterings of samples 
from only MM patients. We notice that there still appear 
to be some groups of samples even though all of the 
patients have the disease. This might indicate that some 
of the samples are genetically related in such a way that 
those patients would respond similarly to treatment. 
Figure 7 (see page 11) shows the results of clustering 
using a set of 50 completely randomized expression 
values. Because the data are randomly distributed, 
we should not expect to see any clustering pattern 
Interestingly, however, we can see some possible 
group, even though there should be no structure to the 
data. But when we compare figures 6 and 7, the group-
ings of random  values in figure 7 are less distinct t 
han the groups of real values in figure 6. We can 
also see that the distances between random values in 
figure 7 are much longer than the distances between 
real values in figure 6.
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Percentage
Correctly
Classified
MM
96.79%
Healthy
84.44%
MM
93.58%
MGUS
38.10%
MGUS
91.11%
Normal
71.43%
Table 3. Results from using logistic regression to predict class 
membership (MM, MGUS, or Healthy). The effectiveness of the 
model is evaluated using cross validation. Each entry in the table 
is the percentage of samples correctly classified.
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Consequently, because the clustering algorithm 
forces some configuration, we must be careful in 
deducing that there are significant relationships among 
the samples. A statistician should use these clustering 
methods carefully, especially when communicating with 
nonstatisticians, so as not to overinterpret any apparent 
structure in the data. Interpreting the groups within a 
hierarchical cluster is somewhat subjective and does 
not follow a formal structure of decision-making as in 
hypothesis testing.
Other classification and clustering techniques 
commonly used on microarray data include “nearest 
shrunken centroid” classification (Tibshirani et al. 2002) 
and “model-based clustering” (Yeung et al. 2001).
Advanced Techniques
Advanced techniques are often applied to microarray 
data and new methods are constantly being developed 
to better analyze the data. Some examples of advanced 
techniques we frequently use include:
• Time Series Analysis – With time series analysis we 
can observe trends over time for organisms like yeast, 
for example, that change rapidly (Zhao et al. 2001).
• Partial Least Squares and Principal Component 
Analysis—Both of these methods allow the analyst to 
reduce the dimensions of the data in a meaningful 
way. Since many data sets have hundreds of samples 
with thousands of dimensions, it is important to reduce 
the dimensions in a way that captures the signal while 
discounting the noise (Nguyen and Rocke 2002; Yeung 
and Ruzzo 2001; Bair and Tibshirani 2004).
• Discriminant Analysis—This is a way of 
partitioning the data and can be used for classification 
problems (Dudoit et al. 2002).
• Survival Analysis—This technique is used to 
evaluate data with censored endpoints that are common 
in medical studies. “Censoring” occurs when a patient 
dies or for some other reason does not complete 
the study. The Cox proportional hazards model—the 
standard survival model—is not equipped to handle 
thousands of explanatory variables and so variable 
reduction techniques must be used to fit survival 
analysis models (Pauler et al. 2004; Bair and Tibshirani 
2004).
What Statistical Issues are Specific to 
Microarray Analyses?
Many of the techniques used to analyze microarray 
data are straightforward applications of well-known 
methodology and some of the established procedures 
can be modified to handle large data sets. However, 
some issues cannot be dealt with using standard 
statistical approaches and research is needed into new 
techniques to address specific problems.
One problem with microarray data is that the 
number of genes is almost always bigger than the 
sample size. This type of sparse data makes inverting 
covariance matrices impossible, which in turn forces 
us to pare down the number of variables for methods 
like regression analysis that use inverted covariance 
matrices to calculate least squares estimates. Some data 
reduction techniques have been developed, but there 
is more work to be done to develop new methods for 
ascertaining what set of variables would be the most 
informative.
Because we often are interested in understanding 
particular genes, we use gene-by-gene techniques like 
t-tests, ANOVA, or regression analysis. Each time a 
gene is judged to be significant according to one of 
these tests, there is the risk of producing a Type I 
error.  If we were to set our significance level to α = 
0.05 and run t-tests on 10,000 genes, we would expect 
500 genes to test as significant, even if there is no signal 
in the data. The problem of controlling for this type 
of error in general has been studied widely (Benjamini 
and Hochberg 1995) and is now being researched 
in the specific context of microarray data (Storey, 2002).
Another problem is that microarray data do not 
conform to the usual assumptions of many standard 
statistical tests. The data themselves are in units of 
fluorescence and are often highly skewed right and 
can even be negative if a “background adjustment” 
is needed when the background fluorescence is 
brighter than the foreground fluorescence. Often log 
transformations (with some ad hoc adjustment for 
the negative values) give data that are moderately 
symmetric. However, log-transformed microarray data 
may still have highly unequal variances for which 
many techniques (like ANOVA) are not robust. 
Transformations and normalizations for microarray data 
are being researched so that the results from standard 
statistical analyses, based on the usual requirements, are 
reliable (Durbin et al. 2002).
What Software is Available for Microarray 
Analyses?
New software is constantly being developed to 
perform analyses specifically for microarray data. 
Because the technology is relatively new, much of the 
software is being developed in academia and is freely 
available. Below are summaries of a few of the most 
commonly used software programs. The synopses are 
based on my experience and not meant as endorsements 
or condemnations of any of the software.
• Bioconductor: This is a free program that runs 
in R. It is designed for statisticians who are researching 
new techniques on microarray data. It is flexible, though 
it does require basic programming knowledge of R or 
S-Plus. Bioconductor also has multiple graphs and 
features designed specifically for extracting information 
from microarray data.
www.bioconductor.org
• SAM & PAM: Significance Analysis of Microarrays 
(SAM) and Prediction Analysis of Microarrays (PAM) are 
free software programs that add-in to Microsoft Excel 
or R. SAM produces pictures and lists of genes that are 
Continued on page 12
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Figure 4. Hierarchical clustering of 85 randomly selected MM, MGUS, and Healthy Samples.  
Figure 5. Hierarchical clustering analysis of 24 samples from healthy patients.
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Figure 6. Hierarchical clustering analysis of 50 samples from MM patients.  
Figure 7. Hierarchical clustering analysis of 50 random expression values.
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significant across groups, while controlling for the false 
discovery rate. It also correlates gene expression to clinical 
parameters. PAM performs classification of microarray 
data using nearest shrunken centroid methods.
www-stat.stanford.edu/~tibs
• Cluster & Treeview: These programs perform 
hierarchical clustering across both samples and genes. 
The results are displayed in tree-based images with 
label information and colors representing expression 
levels. Cluster and Treeview are both freely available 
software programs.
http://rana.lbl.gov/EisenSoftware.htm
• BRB ArrayTools: This software is designed as 
a free add-in to Microsoft Excel for visualization and 
statistical analysis of microarray data. It contains various 
methods including class comparison, class prediction, 
and permutation tests for significance levels.
http://linus.nci.nih.gov/BRB-ArrayTools.html
• GeneSpring: This package is widely used by 
biologists and geneticists. It is user friendly and has 
many good statistical techniques, including adjustments 
for multiple comparisons. However, it is not free and not 
as flexible for statistical research as other programs.
www.sigenetics.com/GeneSpring/GeneSpring.html
Summary
For biologists, microarray technology has opened new 
avenues to access a new world of knowledge quickly 
and inexpensively. Never before has it been possible to 
study so many genes simultaneously on so many samples. 
However, any technology is limited by its ability to extract 
information.
As statisticians, it is our role to ensure that the 
information obtained from microarray experiments is 
valid and interpreted appropriately. Many of the statistical 
concepts from the last century are applicable to microarray 
analysis, but we must also open our minds to new 
techniques and methodologies that will be better suited for 
this new generation of data. In this century, our contribution 
to science will be to develop the analyticaltools that can 
handle future generations of data yet to come.  
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